Skip to main content

Advertisement

Table 2 Diagnostic criteria of headache related to the use and to the withdrawal of hormones according to the different editions of the International Classification of Headache Disorders (ICHD)

From: Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)

ICHD, II edition, 2004
 8.3.1 Exogenous hormone-induced headache
  A. Headache or migraine fulfilling criteria C and D
  B. Regular use of exogenous hormones
  C. Headache or migraine develops or markedly worsens within 3 months of commencing exogenous hormones
  D. Headache or migraine resolves or reverts to its previous pattern within 3 months after total discontinuation of exogenous hormones
 8.4.3 Estrogen-withdrawal headache
  A. Headache or migraine fulfilling criteria C and D
  B. Daily use of exogenous estrogen for ≥3 weeks, which is interrupted
  C. Headache or migraine develops within 5 days after last use of estrogen
  D. Headache or migraine resolves within 3 days
ICHD, III edition, beta version, 2013
 8.1.12 Headache attributed to exogenous hormone
  A. Any headache fulfilling criterion C
  B. Regular intake of one or more exogenous hormones
  C. Evidence of causation demonstrated by both of the following:
    1. Headache has developed in temporal relationship with the commencement of hormone intake
    2. One or more of the following:
     a) headache has significantly worsened after an increase in the dosage of the hormone
     b) headache has significantly improved or resolved after a reduction in the dosage of the hormone
     c) headache has resolved after cessation of hormone intake
     d) Not better accounted for by another ICHD-3 diagnosis
 8.3.3 Estrogen-withdrawal headache
  A. Headache or migraine fulfilling criterion C
  B. Daily use of exogenous estrogen for ≥3 weeks, which has been interrupted
  C. Evidence of causation demonstrated by both of the following:
    1. headache or migraine has developed within five days after the last use of estrogen
    2. headache or migraine has resolved within three days of its onset
  D. Not better accounted for by another ICHD-3 diagnosis
ICHD, III edition, 2018
 8.1.10 Headache attributed to long-term use of non-headache medication
  A. Headache present on ≥15 days/month and fulfilling criterion C
  B. Long-term use of a medication has occurred for purposes other than the treatment of headache
  C. Evidence of causation demonstrated by at least two of the following:
    1. headache has developed in temporal relation to the commencement of medication intake
    2. one or more of the following:
     a) headache has significantly worsened after an increase in dosage of the medication
     b) headache has significantly improved or resolved after a reduction in dosage of the medication
     c) headache has resolved after cessation of the medication
    3. the medication is recognized to cause head- ache, in at least some people, during long- term use
  D. Not better accounted for by another ICHD-3 diagnosis
 8.3.3 Estrogen-withdrawal headache
  A. Headache or migraine fulfilling criterion C
  B. Daily use of exogenous estrogen for ≥3 weeks, which has been interrupted
  C. Evidence of causation demonstrated by both of the following:
    1. headache or migraine has developed within five days after the last use of estrogen
    2. headache or migraine has resolved within three days of its onset
  D. Not better accounted for by another ICHD-3 diagnosis